Centers for Disease Control and Prevention

Atlanta, Georgia 30341

0 studies enrolling now · 23 studies all time

What they study most

AIDS, Adverse Drug Event, Adverse Event Following Immunisation, Adverse Event Following Immunization, Apnea, Apnea Neonatal, Asthmatic, Birth Outcomes, COVID-19, Febrile Seizure, Fever, Fever After Vaccination

Studies at this site

• Safety of RSV Preventive Monoclonal Antibody — Recruiting now
• Immunogenicity of Influenza Vaccinations — Completed
• Safety of Pediatric COVID-19 Vaccination — Completed
• Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children — Completed
• Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV — Stopped early
• Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study — Completed
• Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women — Completed
• Observational Maternal COVID-19 Vaccination Study — Completed
• Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations — Completed
• Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old — Completed
• Fever After Simultaneous Versus Sequential Vaccination in Young Children — Completed
• Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines — Completed
• Presyncope (Syncope) Prevention Study — Completed
• FLUAD® vs. Fluzone® High-Dose Study — Completed
• Helicobacter Pylori Genome Project (HpGP) — Stopped early
• Botswana TDF/FTC Oral HIV Prophylaxis Trial — Completed
• Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study — Completed
• Influenza Vaccine Feasibility Study in Children With Persistent Asthma — Completed
• Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging — Completed
• FeverText: Assessing Fever Rates After Vaccination During the 2011-12 Influenza Season Using Text Messaging — Completed
• Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014 — Completed
• Botswana Study of UC-781 Vaginal Microbicide — Withdrawn before enrolling
• Botswana Tenofovir Oral HIV Prophylaxis Trial — Stopped early